Novo Nordisk A/S Logo

Novo Nordisk A/S (NOVOBN)

BMV

Currency in MXN
800.00
0.00 (0.00%)

Real-time Data

02:30 PM

Day's Range

800.00
800.00

52 wk Range

630.00
1,179.99

Overview - NOVOBN - Novo Nordisk A/S

Key Statistics

Valuation

Enterprise Value

9.61T

P/E (Trailing)

‪11.49‬

PEG Ratio

‪-0.56‬

Price / Sales (TTM)

‪10.73‬

Price / Book

‪6.06‬

EV / EBITDA

‪20.94‬

Profitability

Gross Margin

‪78.21%‬

Profit Margin

‪35.34%‬

Operating Margin

‪42.54%‬

Return on Assets

‪18.72%‬

Return on Equity

‪59.81%‬

Ownership

Shares Outstanding

4.42B

Float

3.17B

Held by Insiders

‪5.28%‬

Held by Institutions

‪33.32%‬

Price stats

Beta

‪0.34‬

50-Day Avg

‪836.05‬

200-Day Avg

‪842.31‬

Dividends

Payout Ratio

‪44.57%‬

Frequency

Semi-Annual

Market Cap - NOVOBN - Novo Nordisk A/S

Peers - NOVOBN - Novo Nordisk A/S

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on BMV.

Profile Summary - NOVOBN - Novo Nordisk A/S

About

Novo Nordisk A/S is a global pharmaceutical company specializing in research, development, and manufacturing of treatments for serious chronic diseases. Founded through the 1989 merger of Danish insulin pioneers Nordisk Insulaboratorium and Novo Terapeutisk Laboratorium, it traces its roots to 1923 when commercial…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees67.90K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.